Dr. Reddy’s in licenses biosimilar for J&J’s multiple myeloma therapy
Dr. Reddy’s (NYSE:RDY) on Thursday announced a licensing agreement with China-based Shanghai Henlius Biotech (OTCPK:SGBCF) to jointly develop and market a biosimilar version of Darzalex, a multiple ...
Jim Cramer on Palo Alto Networks, Inc. (PANW) CEO Nikesh Arora: ‘He Created $104 Billion In Value’
We recently compiled a list of the Jim Cramer Highlighted Buying Opportunities in 13 Stocks. In this article, we are going to ...